Enanta Pharmaceuticals (ENTA)
NASDAQ:ENTA

Enanta Pharmaceuticals Insider Trading Activity

Trend: Corporate Insiders Bought Shares Worth $118.4K in the Last 3 Months.

ENTA Insider Transactions

The data in the graph is based on publicly available reports of insider transactions, as reported to the SEC.
See the number of buy and sell transactions by insiders for this stock over the past year.

Insider Confidence Signal

Positive
Sector
Average
Stock Sentiment
Sold
Bought
Based on 1 informative insider transaction by 1 unique insider from last 3 months.
The sentiment expressed in the Insider Confidence Signal is based on insider transactions over the past 3 months.

Insider Buy and Sell Transactions​

Insider Name
Role
Star Ranking
Transaction
Amount
Date
Follow
SEC
Upgrade Banner
President & CEO,Director
Informative Buy
$118442
President & CEO,Director
Uninformative Sell
$170450
President & CEO,Director
Uninformative Buy
President & CEO,Director
Uninformative Sell
$266670
Sr. VP & Chief Medical Officer
Not Ranked
Uninformative Sell
$879150
Sr. VP & Chief Medical Officer
Not Ranked
Uninformative Sell
$1167690
Sr. VP & Chief Medical Officer
Not Ranked
Uninformative Sell
$73827
Sr. VP & Chief Medical Officer
Not Ranked
Uninformative Buy
Sr. VP & Chief Medical Officer
Not Ranked
Uninformative Sell
$810419
Sr. VP & Chief Medical Officer
Not Ranked
Uninformative Sell
$1227587
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis